Inogen Inc (INGN)
Healthcare
Medical Devices
6.50 $
+0.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Inogen Inc (INGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.4% of the shares are freely tradable; institutional investors hold 77.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
77.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
12.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
87.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
27Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 6.08 | 1,647,084 | -4.1 | 03/31/2026 |
| Vanguard Group Inc | 5.25 | 1,421,636 | -0.6 | 12/31/2025 |
| Armistice Capital, LLC | 4.43 | 1,200,000 | -5.1 | 03/31/2026 |
| Acadian Asset Management LLC | 4.00 | 1,083,483 | +5,444.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.83 | 1,036,705 | +0.0 | 03/31/2026 |
| Ameriprise Financial Inc | 3.17 | 859,543 | -0.1 | 03/31/2026 |
| Dafna Capital Management LLC | 3.12 | 845,179 | +2.2 | 03/31/2026 |
| Point72 Asset Management, L.P. | 2.37 | 642,366 | +218.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.71 | 739,966 | +0.0 | 04/30/2026 |
| CS McKee Micro Cap Value | 2.42 | 662,450 | +0.0 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.